Sivik Global Healthcare LLC Agios Pharmaceuticals, Inc. Transaction History

Sivik Global Healthcare LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $1.35 Million - $2.24 Million	-40,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $1.38 Million - $2.14 Million	40,000 New	40,000 $2.14 Million
Q3 2019 Nov 12, 2019	SELL	$32.4 - $49.58 $972,000 - $1.49 Million	-30,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $230,850 - $340,500	5,000 Added 20.0%	30,000 $1.5 Million
Q1 2019 May 08, 2019	BUY	$45.92 - $67.67 $459,200 - $676,700	10,000 Added 66.67%	25,000 $1.69 Million
Q4 2018 Feb 12, 2019	SELL	$42.73 - $76.53 $213,649 - $382,650	-5,000 Reduced 25.0%	15,000 $692,000
Q3 2018 Nov 13, 2018	SELL	$71.67 - $91.95 $358,350 - $459,750	-5,000 Reduced 20.0%	20,000 $1.54 Million
Q2 2018 Aug 06, 2018	BUY	$73.22 - $99.55 $364,708 - $495,858	4,981 Added 24.88%	25,000 $2.11 Million
Q4 2017 Feb 08, 2018	BUY	$52.12 - $72.33 $1.04 Million - $1.45 Million	20,019	20,019 $1.14 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.